Undiscovered Gems with Strong Fundamentals in April 2025
In the current landscape, the UK market has been grappling with challenges as evidenced by the recent declines in key indices like the FTSE 100 and FTSE 250, driven by weak trade data from China and broader global economic concerns. Despite these headwinds, investors can find opportunities in stocks with strong fundamentals that are well-positioned to weather such uncertainties.
Name
Debt To Equity
Revenue Growth
Earnings Growth
Health Rating
BioPharma Credit
NA
7.22%
7.91%
★★★★★★
B.P. Marsh & Partners
NA
29.42%
31.34%
★★★★★★
Livermore Investments Group
NA
9.92%
13.65%
★★★★★★
Andrews Sykes Group
NA
2.15%
4.93%
★★★★★★
Rights and Issues Investment Trust
NA
-7.87%
-8.41%
★★★★★★
London Security
0.22%
10.13%
7.75%
★★★★★★
MS INTERNATIONAL
NA
13.42%
56.55%
★★★★★★
Goodwin
37.02%
9.75%
15.68%
★★★★★☆
FW Thorpe
2.95%
11.79%
13.49%
★★★★★☆
AltynGold
73.21%
26.90%
31.85%
★★★★☆☆
Click here to see the full list of 59 stocks from our UK Undiscovered Gems With Strong Fundamentals screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Value Rating: ★★★★★★
Overview: Science Group plc is a science, engineering, and technology company that offers consultancy services and systems solutions across the UK, Europe, North America, Asia, and globally with a market capitalization of £196.19 million.
Operations: Science Group generates revenue primarily from consultancy services (£72.21 million) and systems businesses, including audio chips and modules (£11.97 million) and submarine atmosphere management (£25.86 million). The company also earns from freehold properties (£3.95 million), while inter-company property income is recorded as negative (-£3.31 million).
Science Group, a nimble player in the UK market, has demonstrated robust financial health with its debt to equity ratio dropping from 45% to 14% over five years. The company boasts high-quality earnings and impressive interest coverage of 104.8 times EBIT, ensuring stability. Despite a slight dip in sales to £110.67 million from £113.34 million, net income surged to £12.02 million from £5.52 million last year, reflecting strong profit growth of 117.6%. Trading at a significant discount of 50.7% below estimated fair value and completing a share buyback worth £4.69 million enhances its appeal as an investment prospect.
Dive into the specifics of Science Group here with our thorough health report.
Examine Science Group's past performance report to understand how it has performed in the past.
Simply Wall St Value Rating: ★★★★★★
Overview: BioPharma Credit PLC is an investment trust that focuses on investing in interest-bearing debt assets, with a market cap of $966.70 million.
Operations: The company generates revenue primarily through its investments in debt assets secured by royalties, amounting to $150.03 million.
BioPharma Credit shines with a robust financial profile, boasting earnings growth of 12.7% over the past year, outpacing the Capital Markets industry average of 7.4%. The company operates debt-free, eliminating concerns around interest coverage and enhancing its financial flexibility. Trading at a notable 31.1% below estimated fair value suggests potential for appreciation. Recent results show revenue climbing to US$150 million from US$135 million in the previous year, while net income reached US$122 million compared to US$108 million prior. A buyback saw the repurchase of over 79 million shares for $69.65 million, reflecting confidence in its valuation and future prospects.
Navigate through the intricacies of BioPharma Credit with our comprehensive health report here.
Review our historical performance report to gain insights into BioPharma Credit's's past performance.
Simply Wall St Value Rating: ★★★★☆☆
Overview: McBride plc, with a market cap of £246.81 million, manufactures and sells private label household and personal care products to retailers and brand owners across the United Kingdom, Europe, Asia-Pacific, and other international markets.
Operations: McBride generates revenue primarily from its Liquids segment (£535.30 million) and Unit Dosing segment (£235.20 million), with additional contributions from Powders, Aerosols, and Asia Pacific segments.
Trading at a significant discount, McBride stands out with its earnings growth of 122.2% last year, outpacing the household products industry average of 26.1%. The company's net income rose to £19.4 million from £12.7 million, while basic earnings per share increased to £0.114 from £0.073 in the same period last year. Despite a high net debt to equity ratio of 135.8%, its interest payments are well covered by EBIT at 7.8 times coverage, reflecting solid financial management amidst a high debt backdrop and offering potential value for investors seeking opportunities in smaller firms within the UK market.
Click here to discover the nuances of McBride with our detailed analytical health report.
Gain insights into McBride's historical performance by reviewing our past performance report.
Click this link to deep-dive into the 59 companies within our UK Undiscovered Gems With Strong Fundamentals screener.
Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AIM:SAG LSE:BPCR and LSE:MCB.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
3 reasons I won't let ChatGPT anywhere near my ISA!
A lot of peopleare excited about the potential of AI tools like ChatGPT to help them find information and make suggestions. But while some hope such a tool can help them decide what shares to buy for their ISA, I will not be touching that approach with a bargepole! Why not? Here are three of my reasons! Nobody knows what will happen in future, including in the stock market. Smart human investors consider a company's track record, but in the context of trying to decide how it may perform in future. AI tools often like concrete rather than abstract inputs. I fear that means they may over-emphasise a company's known past performance, instead of synthesizing its unknown possible future performance. Each investor is different. But, if 100 investors were to ask an AI tool what the best shares to buy are, I think the answers may be fairly consistent. Now in fairness, ChatGPT did respond to my prompt, 'what's the best share for my ISA?' by saying it can depend on factors like one's investment goals, risk tolerance, and time horizon. Still, not paying enough attention to individual context could be highly problematic. Different investors have their own objectives and risk tolerances. Something I have noticed ChatGPT seems to struggle with fairly regularly is clearly distinguishing between facts and people's opinions. Asking it what I ought to with my ISA, I fear that part of the response may potentially mix up facts and opinions. For example, when I asked ChatGPT what the best share is for my ISA, although it said it would need more information as 'best' depends on different factors, it nonetheless went on on the same page to offer me a list of 'popular and potentially strong-performing shares commonly held in ISAs (based on current sentiment)'. What 'current sentiment' (whatever that means: whose sentiment is it?) thinks are the best shares for my ISA may not actually be the best shares for my ISA – or anywhere close. For example, one share on the list is one I own: Diageo (LSE: DGE). I do think it has strong prospects, which is why I bought it. But the share price performance has been poor: the FTSE 100 stock has fallen 28% in a year. What about the dividend? Diageo's 4.1% yield beats the FTSE average but is nowhere near the highest yield on the index. Yes, it has a strong track record of annual dividend increases – but nowhere near as strong as Spirax, for example. So, is Diageo really the 'best share for my ISA'? It could turn out to be. After all, it has strong brands, a large addressable market, proven business model, and unique assets. But it also has substantial debt and faces changing market dynamics that could see alcohol consumption fall, hurting Diageo's sales and profits. In other words, while Diageo may turn out to be the best share for my ISA, there are far too many unknowns to have any certainty. Investing takes time, skill, a sense of one's own objectives and risk tolerance, as well as an ability to interpret facts. I will not be leaving that to ChatGPT! The post 3 reasons I won't let ChatGPT anywhere near my ISA! appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool C Ruane has positions in Diageo Plc. The Motley Fool UK has recommended Diageo Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Yahoo
2 cheap FTSE 100 shares to consider buying in June
How do we tell if a FTSE 100 stock looks cheap? One way is to seek out share prices that have fallen this year, and that brings Associated British Foods (LSE: ABF) into view. The shares are up from their 52-week low in March, but we're still looking at a 12-month fall of 20%. Some of the weakness has to be down to retail fears facing the company's Primark high street chain. We also have at a collection of five different business here, with Grocery, Ingredients, Sugar, and Agriculture divisions added to Retail. That brings diversification, which is a good thing. But it can also suggest a company lacks focus, and top management have to keep their eyes on numerous balls. With first-half results in April, CEO George Weston said he was 'frustrated with the results in our Sugar business.' But the other four are doing fine, in line with full-year guidance. The update gave the share price a boost at the time. Forecasts indicate a fall in earnings per share for the full year, and that has to be holding the stock back. But analysts expect a return to earnings growth that could drop the price-to-earnings (P/E) ratio to under 9.5 by 2027. Associated British Foods had net debt of £2.8bn at 1 March, up from £2.5bn a year previously. Against a market cap of nearly £15bn, that doesn't worry me too much. But it's worth keeping an eye on. There's risk from retail exposure, and a possibly perceived lack of focus. But I think long-term investors should consider it. Looking for FTSE 100 stocks on low P/E valuations can also throw up candidates. And that draws my attention to M&G (LSE: MNG). M&G seems to come up in a number of my searches on different factors, like its big 8.3% forecast dividend yield. There's a forecast P/E of 10 on the cards for the current year. And a mooted recovery from the past couple of tough years could see it drop close to eight by 2027. Investment management companies are often on lower P/Es and can be cyclical. But the predicted earnings growth over the next few years should cover the dividends, which are also expected to rise. The cover might be a bit thin though. With 2024 results released in March, CEO Andrea Rossi spoke of 'two new targets for 2025-2027: to grow adjusted operating profit before tax on average by 5% or more per annum, and to generate £2.7 billion of operating capital.' The boss added: 'I am delighted to announce that today we are moving to a progressive dividend policy, starting with a 2% increase for the 2024 total dividend per share.' That all sounds ambitiously positive. But the risk hasn't gone away. The world seem to be lurching from one trade-related economic crunch to another on an almost daily basis. And if M&G's dividends can't keep up with inflation, the shares could take another knock. But I see a decent chance of a bull run here and feel it's worth a closer look. The post 2 cheap FTSE 100 shares to consider buying in June appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Associated British Foods Plc and M&g Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025
Yahoo
7 hours ago
- Yahoo
A £10,000 investment in Standard Chartered shares 10 years ago is now worth…
Despite some operational problems, a focus on fast-growing developing regions means Standard Chartered's (LSE:STAN) shares have provided solid returns over the last decade. At £11.56 per share, the FTSE 100 bank has risen 20.3% in value from the 961.3p it traded at 10 years ago. It's an ascent that would have turned a £10,000 lump sum investment back then into a cool £12,028 today. The overall return improves further too, when adding in dividends over the last decade. Since mid-2015, dividends from the business have totalled 109.7p per share. As a consequence, a £10k investment in the bank back then would have produced a total shareholder return of £13,169, or 31.7%. That's not bad, but it's hardly a stunning result. To put that in perspective, the broader Footsie's delivered a return of 82.9% in that timeframe. Fellow emerging market bank HSBC has also delivered better returns over that time. With capital gains and dividends combined, StanChart's Asian rival's total returns stand just above 100%. As I alluded to above, the bank's suffered a number of performance-denting setbacks between 2015 and 2020. Compliance issues resulted in severe reputational damage and heavy financial penalties. It also had to heavily restructure to improve performance and beef up the balance sheet. But with these issues now in the distant past, could Standard Chartered shares deliver better returns from now on? Like any bank, the company's highly sensitive to broader economic conditions. During downturns, profits can slump as demand for financial services declines. At the same time, loan impairments can shoot through the roof. This is a significant danger for the FTSE company as the key Chinese economy splutters, causing wider problems across its Asia Pacific region. Standard Chartered sources around three-quarters of revenue from customers in this territory. Worryingly for the country's banks, China's property sector continues to soften as well. StanChart's been no stranger to substantial real estate-related writedowns in recent years. Established banks like this also face intense competition from digital banks. According to Statista, net interest income among digital-only competitors will grow at an annualised rate of 9.36% between 2025 and 2029. Having said that, Standard Chartered's enjoying its own successes in the digital realm. Its Mox and Trust platforms (in Hong Kong and Singapore, respectively) have enjoyed strong take-up following their launches in recent years. And the bank has significant resources to continue building its presence in this key growth segment. What's more, while Asian banks may suffer some discomfort in the near term, the long-term outlook for the continent remains extremely bright. As with StanChart's African and Middle East markets, there's scope for substantial profits growth as personal wealth levels climb and populations steadily increase. Today, the stock trades on a forward price-to-earnings (P/E) ratio of 8.2 times. It also trades on a sub-1 price-to-earnings growth (PEG) ratio of 0.6. Such readings fail to reflect Standard Chartered's enormous growth potential, in my view. I think it's a top FTSE 100 share to consider right now. The post A £10,000 investment in Standard Chartered shares 10 years ago is now worth… appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool HSBC Holdings is an advertising partner of Motley Fool Money. Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended HSBC Holdings and Standard Chartered Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
